Latham & Watkins

Christoph Engeler

Deals
1
Latest
Sep 2026

Firm

Often works with

Deals

US deals dated after 30 September 2026 are still being collected.

Columns
Deals Christoph Engeler was named on, most recent first
Sep 2026 portfolio of 20 mature medicines and three manufacturing sites SanofiCheplapharmAsset saleLegal adviser to Cheplapharm (acquirer)Announced–Pharma+1Cheplapharm acquisition of portfolio of 20 mature medicines and three manufacturing sites

Deals where Christoph Engeler is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.